Dr. Tolat and the Department of Electrophysiology are participating in this study is to demonstrate if the AcQBlate Force Sensing System is safe and effective when used to ablate the cavotricuspid isthmus (CTI) for the treatment of typical atrial flutter when compared to a literature-based control. The System is designed for electrophysiologic (EP) mapping and RF ablation of atrial flutter.
-
AcQMap US Registry is an observational, prospective, multi-center, open-label registry designed to provide clinical outcomes data regarding the commercial, real-life experience with the diagnostic AcQMap System being conducted by Dr. Tolat and the Department of Electrophysiology.
-
This is a prospective, multicenter, open-label, randomized active controlled clinical trial to determine if apixaban is non-inferior to warfarin (INR target range 2.0 - 3.0) for the primary composite outcome of valve thrombosis and valve-related thromboembolism in patients with an On-X mechanical heart valve implanted in the aortic position.
-
The purpose of the clinical study is to evaluate the safety and effectiveness of the Cardioblate iRF and CryoFlex hand held devices to expand the Indication for use to include the treatment of persistent atrial fibrillation and long-standing persistent atrial fibrillation (non-paroxysmal AF) in subjects undergoing concomitant cardiac surgery.
-
August 11, 2010
Hartford Hospital is currently recruiting patients with an irregular heartbeat to participate in a research study. Patients will be randomly selected for either ablation or drug therapy, neither of which is experimental, and will receive follow-up care every six months for two years.
-
September 24, 2013
Investigators from the Preventive Cardiology Department at Hartford Hospital are examining how genetic differences may explain why people respond differently to common cholesterol-lowering medications. Age 18-65, elevated cholesterol, not taking a cholesterol lowering drug.
-
March 07, 2014
Healthy volunteers are wanted for a heart failure research study. This research study will investigate a protein biomarker in advanced heart failure. Volunteers will need to undergo one blood draw.
-
September 05, 2014
The Preventive Cardiology Department is conducting a research study to examine the effects of a study drug (ETC-1002) on cholesterol levels in people currently taking statins. Participants who finish the entire study will be compensated $675 for their time.
-
January 03, 2017
Local physicians are conducting a research study of an investigational medication to assess its ability to reduce heart attacks, strokes or other cardiovascular events. Participants must be age 45 or older, taking cholesterol lowering medication, and have elevated triglycerides. They must also have a history of one or more of the following: Previous heart attack or stroke, Heart disease or Diabetes. All
January 03, 2017
Research volunteers are wanted for examination of vascular function in testicular and Hodgkins cancer survivors. Participants must be 20-55 year old men previously treated for testicular cancer to be eligible. Participants who finish the study will receive free health information and financial compensation for their time.